Empirical Antibiotic Treatment for Cellulitis
First-Line Empirical Treatment Options
- The American College of Physicians recommends a 5- to 6-day course of antibiotics active against streptococci as first-line therapy for nonpurulent cellulitis, with consideration for MRSA coverage in specific risk situations 1
- Beta-lactam antibiotics targeting streptococci are recommended as first-line therapy for typical nonpurulent cellulitis, with options including cephalexin 500 mg orally four times daily, dicloxacillin 500 mg orally four times daily, and clindamycin 300-450 mg orally three times daily for penicillin-allergic patients 2, 3
- The duration of therapy is 5-6 days for most cases of uncomplicated cellulitis, with treatment extended if the infection has not improved within this period 1, 2
Inpatient Management
- For severe infections with systemic signs, altered mental status, or hemodynamic instability, vancomycin plus either piperacillin-tazobactam or imipenem/meropenem is recommended 2, 4
- For moderate infections requiring hospitalization without severe systemic symptoms, IV beta-lactam antibiotics such as cefazolin or nafcillin are recommended, with consideration for adding MRSA coverage if no clinical response 2, 4
When to Consider MRSA Coverage
- MRSA coverage should be added to the empiric regimen in situations such as purulent cellulitis, penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, injection drug use, and systemic inflammatory response syndrome 1, 2, 4
Clinical Considerations and Caveats
- Streptococci remain the predominant pathogens in nonpurulent cellulitis, with S. aureus (including MRSA) more common in purulent infections 1, 2
- Adjunctive measures such as elevation of the affected area, treatment of predisposing factors, and examination of interdigital spaces for fissuring or maceration can improve outcomes 2
- Systemic corticosteroids may be considered in nondiabetic patients 2, 4
- Hospitalization criteria include concern for deeper or necrotizing infection, poor adherence to therapy, severe immunocompromise, failure of outpatient treatment, and systemic inflammatory response syndrome 2, 4
- For recurrent cellulitis, prophylactic antibiotics such as oral penicillin or erythromycin twice daily for 4-52 weeks should be considered 2